BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

News: BNO Bionomics Receives FDA Clearance Of IND For Evaluation Of BNC210 In A Phase 2 Social...

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    01/11/21
    21:20
    Post #: 57242069

    Nov 1 (Reuters) - Bionomics Ltd (BNO) :

    • BIONOMICS RECEIVES FDA CLEARANCE OF IND FOR EVALUATION OF BNC210 IN A PHASE 2 SOCIAL ANXIETY DISORDER PREVAIL STUDY
    • BIONOMICS LTD - PREVAIL STUDY REMAINS ON TARGET TO INITIATE BY END OF 2021 AND IS EXPECTED TO READ OUT TOPLINE DATA BY END OF 2022
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS Marquee confirms high-grade antimony ahead of maiden JORC resource
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
NEWS Final toll milling completed at Jeffreys Find Gold Mine
right-arrow Created with Sketch.
NEWS HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.